Description
In this free one-hour video course, Jerrod Johnson, DVM, DABVP (c/f), CVPP, a general practitioner, will share his experiences using STELFONTA® to treat mast cell tumors in practice. He’ll share insights on case selection, administration of the drug, client communication advice, post-injection monitoring, and long term outcomes. With each case, he’ll review step-by-step photos showing each stage of healing. Lastly, he’ll cover the mode of action, indications, dosing, administration, adverse events, and safe use of STELFONTA®.
------------------------
Program Description:
In this webinar, brief information will be provided about the mode of action, indications, dosing, administration, and safety of STELFONTA® (tigilanol tiglate injection). The majority of the webinar will be focused on case sharing by a general practice veterinarian and will illustrate the safe use, administration technique, tumor destruction and wound healing journey.
STELFONTA® (tigilanol tiglate injection) Important Safety Information
● Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation.
● Accidental self-injection may cause severe wound formation.
Learning Objectives
- The attendees will leave with an understanding of the compound tigilanol tiglate and how to safely and successfully administer to their patients. They will also visually see cases treated with the drug as well as hear about some practical tips from colleagues
